To assess changes in tissue microstructure integrity reflected in T1 heterogeneity and prolongation in RRMS and their relationship with clinical disability over the first year following diagnosis, specifically focusing on the correlation between T1 changes and EDSS scores.
Key Findings:
Prolonged T1 components in brain tissues correlate significantly with clinical disability in RRMS, indicating potential for clinical application.
T1 mapping can distinguish microstructural heterogeneity within WML better than visual assessments, suggesting a shift in diagnostic practices.
Changes in T1 prolongation and heterogeneity were observed over the first year post-diagnosis, highlighting the dynamic nature of RRMS.
Interpretation:
Quantitative T1 mapping provides a sensitive, objective measure of microstructural changes in RRMS, potentially improving prognostic capabilities and treatment decisions, thereby influencing clinical practice.
Limitations:
Single-center study may limit generalizability; further multi-center studies are needed to validate findings.
Small sample size for healthy controls may affect test-retest reliability, necessitating larger control groups in future research.
Conclusion:
Quantitative T1 mapping is a promising tool for assessing disease progression and disability in early RRMS, warranting further investigation in larger cohorts to establish its clinical utility.
by James G. Harper, Elizabeth N. York, Rozanna Meijboom, Agniete Kampaite, Michael J. Thrippleton, Patrick K. A. Kearns, Maria del C. Valdés Hernández, Siddharthan Chandran, Adam D. Waldman
